Latest News

Despite the increasing dominance of digital payments, cash continues to hold a vital role in ensuring financial inclusion and economic resilience, particularly for lower-income, rural, and tech-excluded consumers. According to the "Future of Cash in a Digital Economy" report, global trends indicate a reduction in cash usage; however, recent global events have led governments to reconsider fully cashless ecosystems. The preservation of cash accessibility remains critical to safeguarding...

As the Canadian market navigates a backdrop of rising inflation and fluctuating oil prices, the S&P/TSX index has shown resilience with a notable recovery from its mid-March lows. In such times, investors might find potential in penny stocks, which often represent smaller or newer companies. Despite being considered an outdated term by some, these stocks continue to offer intriguing opportunities for those looking beyond traditional investment avenues.

Akeso (SEHK:9926) has come into focus after presenting new lung cancer data at the 2026 European Lung Cancer Congress. The company updated investors on cadonilimab and ivonescimab across difficult non small cell lung cancer settings. See our latest analysis for Akeso. Following the ELCC updates, Akeso's HK$137.8 share price sits on the back of a 25.05% 1 month share price return and 21.62% year to date share price return. The 1 year total shareholder return of 58.48% and 3 year total...

Bank of N.T. Butterfield & Son recently reported fourth-quarter results that surpassed analyst expectations for both net income and revenue, highlighting solid performance across its banking and trust operations. At the same time, the bank moved to expand its trust footprint through the planned acquisition of Rawlinson & Hunter Guernsey and reinforced capital returns via a newly approved share repurchase program. Now we’ll examine how these stronger-than-expected earnings and trust-business...

Roper Technologies (ROP) has been in focus after its latest quarter, where earnings per share topped expectations but revenue did not, while guidance pointed to moderate growth and insiders continued adding to their holdings. See our latest analysis for Roper Technologies. The recent credit facility update and guidance commentary have come against a weaker share price backdrop, with a 90 day share price return of 19.52% and a 1 year total shareholder return decline of 38.89%, pointing to...

The past week’s U.S.–Iran “double-sided” ceasefire agreement, tied to reopening the Strait of Hormuz, has eased concerns over fuel and logistics costs for infrastructure contractors such as Construction Partners. This shift in geopolitical risk could support a release of deferred road and maintenance work, reinforcing Construction Partners’ existing revenue visibility and backlog strength. With expectations for lower fuel and logistics pressures now in focus, we’ll explore how this...

What recent performance suggests about Eastman Chemical (EMN) With no single headline event driving attention today, Eastman Chemical (EMN) is drawing interest after a recent share price around $74.25 and a mixed return profile across the past year and the past 3 months. See our latest analysis for Eastman Chemical. The recent 1-month share price return of 7.22% and year-to-date share price return of 15.40% contrast with a 1-year total shareholder return decline of 1.85%. This suggests...

If you are wondering whether Magnite's current share price reflects its true worth, this breakdown will help you separate price from value. With the stock at US$11.98, recent returns have been mixed, including a 1.5% decline over 7 days, a 0.8% gain over 30 days, a 25.4% decline year to date, and a 23.8% gain over 1 year, while the 5 year return sits at a 66.8% decline. These moves sit against a longer track record that includes a 24.4% gain over 3 years, which can shape how investors think...

AI driven advertising shift puts Aritzia (TSX:ATZ) in focus Aritzia (TSX:ATZ) is drawing fresh attention after reporting a substantial year over year revenue lift linked to Google’s AI Max advertising tool. This development is raising questions about how this operational shift could influence investor views. See our latest analysis for Aritzia. At a share price of CA$127.42, Aritzia has recently seen strong near term momentum, with a 7 day share price return of 11.15% and a 1 month share...

Interactive Brokers Group has launched crypto-asset trading for eligible individual investors in the European Economic Area through its Irish subsidiary, allowing clients to trade 11 leading tokens alongside stocks, options, futures, currencies, bonds, and mutual funds on a single platform. By integrating crypto-assets with traditional securities and highlighting transparent fees and security, Interactive Brokers is positioning its platform as a one-stop hub for European investors who...

In early April 2026, Kingsoft Cloud reported a strong fourth quarter, with both revenue and non-GAAP EBITDA exceeding market expectations and management pointing to very large year-over-year growth in AI-related gross billing. The company also emphasized that intelligent computing demand is set to remain a central focus into 2026, underscoring how AI workloads are becoming a core driver of its cloud business mix. Next, we’ll examine how this surge in AI-related activity and...

In early April 2026, Globant announced it had deployed an AI-based supply chain traceability and compliance solution for CMPC, cutting manual verification times from up to 12 days to minutes while supporting adherence to the EU Deforestation Regulation. This rollout highlights how Globant is applying its AI and SAP capabilities to turn complex sustainability regulation into automated, real-time compliance for global manufacturers. Next, we'll examine how Globant's AI-enabled EUDR compliance...

Why the latest results matter for Sinotrans shareholders Sinotrans (SEHK:598) has just reported full year 2025 earnings, with revenue lower than the previous year but higher net income and earnings per share, alongside a proposed final ordinary dividend of RMB 0.155 per share. See our latest analysis for Sinotrans. The latest figures and proposed dividend come after a relatively steady share price, with Sinotrans at HK$4.99 and modest short term moves but very strong 1 year and multi year...

Earlier this month, Cytokinetics’ Executive Vice President of Research & Development, Fady Malik, exercised stock options and sold 4,500 shares as the company prepared to present at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026. These insider transactions occurred alongside increasingly positive analyst commentary highlighting the recent Myqorzo approval, extended intellectual property protection, and upcoming ACACIA-HCM Phase 3 trial data as key drivers for...

Phase 3 REVEAL-1 results put elegrobart in focus Viridian Therapeutics (VRDN) just reported statistically significant, positive topline data from its Phase 3 REVEAL-1 trial of elegrobart in active thyroid eye disease, a material update that reshapes how you might look at the stock. See our latest analysis for Viridian Therapeutics. The REVEAL-1 update lands after a volatile stretch, with the share price at $14.95, a 7 day share price return of 7.55% but a 90 day share price return of 53.27%,...

Somnigroup International (SGI) has been drawing attention after its inclusion in the ClearBridge Mid Cap Strategy and a sector wide push into furnishings and appliances tied to housing and consumer spending expectations. See our latest analysis for Somnigroup International. Recent trading has been mixed for Somnigroup, with a 4.96% 7 day share price return and a 16.66% 90 day share price decline. However, a 33.59% 1 year total shareholder return suggests that longer term momentum has been...

In recent days, conflicting reports about the timing of Apple’s first foldable iPhone launch, alongside softer App Store trends and ongoing legal and regulatory challenges, have raised fresh questions about the company’s product and services roadmap. At the same time, Apple’s participation in Anthropic’s Project Glasswing and its leadership in global smartphone shipments highlight how cybersecurity collaboration and supply-chain strength are becoming increasingly important pillars of its...

Why AGNC Investment is on income investors’ radar AGNC Investment (AGNC) has been drawing attention as investors weigh its role as a mortgage-focused real estate investment trust, recent share performance and current valuation against its reported US$1.8b in revenue and US$1.5b in net income. See our latest analysis for AGNC Investment. AGNC Investment’s recent share price has edged up over the past month, even though the 90 day share price return is weaker. At the same time, the 1 year total...

Recent analyst reports and corporate moves have put Marex Group (MRX) in focus, with fresh ratings commentary, a planned redomicile to Bermuda, and a proposed share buyback authority all contributing to current investor discussion. See our latest analysis for Marex Group. The recent analyst updates and corporate announcements have come alongside strong momentum in the shares, with a 42.67% 1 month share price return and a 31.92% 1 year total shareholder return from a latest closing price of...

Key recent performance and business profile Exosens (ENXTPA:EXENS) has caught investor attention after a recent pullback, with the share price showing a 5.2% decline over the past day and an 8.6% decline over the past month. At a last close of €60.90, the company carries a market value of about €3.1b and reports revenue of €468.187m with net income of €70.19m, supported by annual revenue and net income growth figures provided. Exosens operates through two primary segments: Amplification and...

What recent returns say about Freedom Holding Freedom Holding (FRHC) has drawn attention after a recent share price move, with the stock showing a 0.2% decline over the past day but double digit gains over the past month. See our latest analysis for Freedom Holding. Putting the recent move in context, Freedom Holding’s 30 day share price return of 14.28% and year to date gain of 21.42%, alongside a 5 year total shareholder return of 205.72%, indicate that momentum has been building over both...

In April 2026, LifeStance Health reported new clinical outcomes data from nearly 180,000 patients across 33 states, showing that most individuals treated for anxiety and depression experienced clinically significant symptom improvement based on GAD-7 and PHQ-9 assessments. The scale of this outcomes analysis, spanning both in-person and telehealth care and using regular symptom tracking to adjust treatment, highlights how LifeStance’s measurement-informed model may support more consistent...

Kontoor Brands recently reported quarterly results showing a very strong year-on-year revenue increase and earnings that exceeded analyst forecasts, alongside upgraded full-year EPS guidance. These results, combined with the Helly Hansen acquisition momentum and leadership changes, have reinforced perceptions that Kontoor’s brand portfolio and operations are gaining strength. Now we’ll examine how this stronger-than-expected revenue growth and upgraded full-year EPS guidance affect Kontoor...

Event context and recent stock move PBF Energy (PBF) has been on many investors’ radar after a choppy few months for the stock, with a modest gain over the past 3 months but mixed shorter term returns. See our latest analysis for PBF Energy. Despite a 12.3% decline in the 7 day share price and a softer 30 day share price return, PBF’s 90 day share price return of 23.6% and very large 1 year total shareholder return suggest earlier momentum that now looks to be cooling. If you are comparing...